The Latest Cardiac and Vascular News
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for the quarter ended September 30, 2017. Recent Highlights and Accomplishments Revenue of $2.4 million in the third quarter 2017 CorPath® GRX installed base increased to 23 systems with the installation of five new systems and […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that it will be participating in the Transcatheter Cardiovascular Therapeutics (TCT) 2017 Conference to be held October 29 – November 2 in Denver, CO. Robotic-assisted percutaneous coronary intervention (PCI) will be featured throughout the conference, including in the exhibit hall, […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release financial and business results for the second quarter of 2017 after the close of trading on Tuesday, November 7, 2017. The Company’s management team will host a corresponding conference call beginning at 4:30 p.m. ET to […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it will incorporate the HeartFlow® FFRct Analysis in a case series of robotic-assisted percutaneous coronary intervention (PCI) procedures with the CorPath® GRX System to evaluate the feasibility and utility of clinical decision support. “We are pleased by this opportunity to […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today the opening of the first international CorPath GRX Robotic Center in Tokyo, Japan. Earlier this year, Corindus partnered with Japan Medicalnext Co., Ltd., a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation), to become the […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced first patient enrollment in the PRECISION GRX Registry, a post-market study to continue market surveillance of the Company’s second generation CorPath GRX System. The PRECISION GRX Registry will include up to 25 sites and enroll up to 1,000 […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that John K. Bakewell has been appointed to its board of directors, effective immediately. Mr. Bakewell will serve as the Chair of the Audit Committee. President and Chief Executive Officer Mark Toland stated, “I am pleased to welcome […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for the quarter ended June 30, 2017. Recent Highlights and Accomplishments Revenue of $2.3 million in the second quarter 2017 Increased CorPath® GRX installed base to 16 systems with three new systems and four purchased upgrades […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today announced that it will release financial and business results for the second quarter of 2017 after the close of trading on Tuesday, August 8, 2017. The Company’s management team will host a corresponding conference call beginning at 4:30 p.m. […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the quarter ended March 31, 2017. Recent Highlights and Accomplishments Realized revenue of $0.8 million in the first quarter 2017 Backlog of an additional $3.0 – $3.5 million in revenue expected to be recognized […]
